Inspyr Therapeutics, Inc.

Industry: Pharmaceuticals (See others in industry)

Address:
2629 Townsgate Rd Suite 215
Westlake Village, CA, 91361
Phone: (818) 597-7552

Filings

Date Type Incremental Cash Raw Filing
2021-07-07 New Unknown SEC link
2021-02-02 New $600,000 SEC link
2021-02-02 New $500,000 SEC link
2021-02-02 New $0 SEC link
2017-09-27 New $320,000 SEC link
2017-04-27 Amended $90,431 SEC link
2017-04-03 New $200,000 SEC link
2016-12-19 New $1,000,000 SEC link
2016-01-06 New $2,492,500 SEC link
2015-07-27 New $2,513,894 SEC link
2014-12-09 New $280,000 SEC link
2014-06-30 New $773,000 SEC link
2013-09-10 Amended $0 SEC link
2013-09-10 Amended $0 SEC link
2013-09-05 New $5,000,032 SEC link
2013-04-05 Amended $988,000 SEC link
2013-01-18 New $881,000 SEC link
2011-05-24 New $2,249,750 SEC link
2011-03-14 Amended $110,695 SEC link
2011-03-04 Amended $300,043 SEC link
2011-02-15 New $3,734,840 SEC link
2010-06-21 New $2,695,000 SEC link
2009-09-18 New Unknown SEC link
2009-08-03 Amended Unknown SEC link
2009-07-08 New Unknown SEC link
2009-07-08 New Unknown SEC link
2009-07-07 New Unknown SEC link
2007-12-12 Paper Filing Unknown Not Available

Directors and Executives (Current and Past)

Name Role
Nancy Jean Barnabei Executive
Richard Buller Director
Michael Cain Director, Executive
Craig Dionne Director, Executive
John Farah Director
Peter Grebow Director
Bo Jesper Hansen Director
Christopher Lowe Director, Executive
John Montgomery Director
Scott Ogilvie Director
Scott Oglive Director
Russell Richerson Executive
Ronald Shazer Executive
Claire Thom Director